• / Free eNewsletters & Magazine
  • / My Account
Home>Funds>Morgan Stanley Ins Muni Secs

Morgan Stanley Ins Muni Secs

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. MEDA: Interim Report, January-March 2016

    MEDA: Interim Report, January-March 2016

  2. Central Garden & Pet Company to Announce Second Quarter Fiscal 2016 Financial Results

    Central Garden & Pet Company to Announce Second Quarter Fiscal 2016 Financial Results

  3. China Eases Path for Foreign Drugmakers' Hepatitis C Treatments

    China Eases Path for Foreign Drugmakers' Hepatitis C Treatments

  4. J&J Makes Push For African Sales -- WSJ

    J&J Makes Push For African Sales -- WSJ

  5. J&J Makes Renewed Push Into Africa

    J&J Makes Renewed Push Into Africa

  6. Trouble in Plain Sight

    IMS Health is on the right track for growth.

  7. Our Take on the Second Quarter

    Despite the Fed taper, a U.S. economy struggling to shake off the winter blues, and a slowing China, stocks continued their remarkable winning streak from April through June.

  8. Novo's Scale Advantages and Drug Lineup Broaden Its Wide Moat

    Regulatory issues that we believe have little impact on Novo Nordisk's long-run prospects have finally helped shares of the leading insulin maker go on sale.

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.